Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qian-Fu Zhao

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceutics|June 26, 2026
Medicinal Plant-Derived Exosome-like Nanoparticles: From Basic Research to Biomedical ApplicationsHuan Deng, Yi-Wen Zhang, Qian-Fu Zhao, et al.
The Kaohsiung Journal of Medical Sciences|July 25, 2020
Low expression of transferrin receptor 2 predict poor prognosis in gastric cancer patientsQian-Fu Zhao, Jun Ji, Qu Cai, et al.
Signal Transduction and Targeted Therapy|January 21, 2025
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8<sup>+</sup>T and tumor cellsGui-Qi Zhu, Zheng Tang, Tian-Hao Chu, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Hepatology International|April 8, 2023
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei-Feng Qu, Meng-Xin Tian, Hong-Wei Lu, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 12, 2024
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migrationChen-Yang Tao, Xiao-Ling Wu, Shu-Shu Song, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceutics|June 26, 2026
Medicinal Plant-Derived Exosome-like Nanoparticles: From Basic Research to Biomedical ApplicationsHuan Deng, Yi-Wen Zhang, Qian-Fu Zhao, et al.
The Kaohsiung Journal of Medical Sciences|July 25, 2020
Low expression of transferrin receptor 2 predict poor prognosis in gastric cancer patientsQian-Fu Zhao, Jun Ji, Qu Cai, et al.
Signal Transduction and Targeted Therapy|January 21, 2025
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8<sup>+</sup>T and tumor cellsGui-Qi Zhu, Zheng Tang, Tian-Hao Chu, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Hepatology International|April 8, 2023
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei-Feng Qu, Meng-Xin Tian, Hong-Wei Lu, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 12, 2024
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migrationChen-Yang Tao, Xiao-Ling Wu, Shu-Shu Song, et al.
Pageof 1